Which Workshop Suits You Best?

Are you working to make ocular treatments longer-lasting, safer, and less invasive?

The 4th Ophthalmic Drug Delivery Summit is back, offering two in-depth content tracks designed to help researchers, scientists, and industry leaders tackle the biggest challenges in ophthalmic drug delivery.

But are you wondering which one suits you best?

Track 1: Stabilization & Sustained Release for Biologics & Peptides

This track focuses on enhancing formulation stability, bioactivity, and therapeutic durability. Key workshops include:

  • Workshop A: Optimize biologic formulation to extend therapeutic durability, led by Re-Vana and AbbVie
  • Workshop C: Address stability and bioactivity challenges in peptide delivery with NanOptima
Track 2: Delivering Gene & Cell Therapies with Precision

Advance your understanding of targeted ocular delivery and immune management in gene and cell therapies. Featured workshops:

  • Workshop B: Navigate vector targeting, route selection, and immune mitigation with 4D Molecular Therapeutics
  • Workshop D: Deliver organized, viable cell therapies to the retina with Cell Cure Neurosciences

Explore the Full Event Guide

  • 3 Days Dedicated to Ocular Drug Delivery Innovation 
  • 22+ Expert Speakers Across Pharma, Biotech, & Academia
  • Exclusive Networking with Leading Ocular R&D Decision-Makers 
  • Insights from Delivery Scientists & Formulation Specialists to Regulatory Experts
  • Real-World Case Studies from Industry Giants & Emerging Innovators 
4th Ophthalmic Drug Delivery Summit
Screenshot-2025-08-12-093824-768x506
Explore the Agenda

Discover the latest innovations transforming ocular drug delivery, from long-acting implants to suprachoroidal access. 

Screenshot-2025-08-12-093745-768x501
Partner With Us

Connect with top-tier drug developers actively seeking expert collaborators across formulation, devices, imaging, and more. 

Screenshot-2025-08-12-093857-768x507
Join Other Ocular Delivery Experts

Register now and look forward to networking with 80+ leading scientists and innovators advancing the future of ophthalmic therapeutics.